Trial Profile
Effectiveness of Paliperidone ER(Invega) on Depressive Symptoms of Schizophrenia Patients: A 8-week Open-label Prospective, Non-comparative Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2019
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 07 Apr 2019 Status changed from recruiting to completed.
- 07 Dec 2015 Planned End Date changed from 1 Jul 2014 to 1 Jul 2016 as reported by ClinicalTrials.gov.
- 07 Dec 2015 Planned primary completion date changed from 1 Mar 2014 to 1 Jul 2016 as reported by ClinicalTrials.gov.